Clinical trial
An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty: a Double-Blind Randomized Placebo-Controlled Trial
NCT05097976 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty: a Double-Blind Randomized Placebo-Controlled Trial
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 1, 2022
- Completion date
- December 31, 2027
- Enrollment
- 420 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
total knee arthroplasty